Diagnosis: Success: Molbio Diagnostics IPO Draws Strong Demand on Final Bidding Day

As Molbio Diagnostics Limited wraps up its final day of bidding, the public offering sees robust participation across institutional and retail investor categories.

Investor Bidding Accelerates on Final Day

MUMBAI — Molecular diagnostic solutions provider Molbio Diagnostics Limited witnessed strong capital commitment on the third and final day of its initial public offering (IPO), with the aggregate issue crossing multiple times subscription thresholds. Operating within the healthcare technology sector, the company opened its public subscription window on August 10, 2026, closing proceedings on August 12, 2026.

The public offering aims to raise Rs 939.70 crores through a combination of a fresh equity issuance worth Rs 200 crores and an offer for sale (OFS) component of Rs 739.70 crores by existing selling shareholders. Investors have bid aggressively for available shares, reflecting sustained interest in health-tech ventures specializing in portable point-of-care testing platforms like the company's flagship Truenat system.

Subscription Breakdown and Grey Market Trends

As bidding progressed toward the final closing hours, overall subscription figures scaled significantly, supported by strong non-institutional investor (NII) appetite and steady retail participation.

• Category Demographics: Non-institutional and high-net-worth investors (HNIs) led the demand surge, while retail individual investors (RIIs) subscribed multiple times to their designated quota. Qualified institutional buyers (QIBs) and eligible employees also registered consistent application tallies.

• Grey Market Premium (GMP): Unofficial market trackers indicate a positive grey market premium, hovering around Rs 145 over the upper price band. Based on current unofficial trends, market participants project a favorable listing premium upon debut.

• Issue Structure: The pricing band for the share sale was fixed between Rs 768 and Rs 807 per share, with a minimum retail application lot size of 18 shares, translating to a baseline investment of Rs 14,526.

Official Sources and Regulatory Disclosures

According to official exchange filings, preliminary prospectus documents, and subscription logs maintained by KFin Technologies Limited, the issue registrar, allotment procedures are slated to be finalized shortly.

"According to officials, net proceeds generated from the fresh issue will be utilized to fund capital expenditures for establishing new research and development infrastructure, expanding production facilities across units in Goa and Visakhapatnam, and supporting general corporate objectives."

Official registrar updates and stock exchange notifications can be independently verified via the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).

Why It Matters

The strong subscription metrics underline investor confidence in specialized diagnostics and scalable med-tech businesses. For prospective retail investors and market analysts, the offering provides exposure to decentralized infectious disease testing frameworks. Practical implications include closely tracking share allotment finalization dates, expected refund initiations, and the tentative trading debut scheduled on primary bourses.

Key Facts at a Glance

• Total Issue Size: Rs 939.70 crores (Fresh issue of Rs 200 crores + OFS of Rs 739.70 crores).

• Price Band: Rs 768 to Rs 807 per equity share.

• Lot Size: 18 shares (Minimum investment of Rs 14,526 for retail applicants).

• Tentative Listing Date: August 17, 2026, on BSE and NSE.

Frequently Asked Questions

What is the current subscription status of the Molbio Diagnostics IPO?

On the final day of bidding, the public issue crossed multiple times subscription, driven by strong non-institutional and retail participation.

What is the price band and minimum investment for the IPO?

The price band is set at Rs 768 to Rs 807 per share, requiring a minimum retail investment of Rs 14,526 for a lot of 18 shares.

When will the share allotment and listing take place?

The basis of allotment is expected to be finalized on August 13, 2026, with equity shares tentatively listing on the BSE and NSE on August 17, 2026.

Where can investors check their share allotment status?

Allotment statuses can be verified directly on the registrar portal of KFin Technologies Limited or via the Bombay Stock Exchange (BSE) website.

Source:

• National Stock Exchange of India (NSE) Filings

• Bombay Stock Exchange (BSE) Corporate Disclosures

• KFin Technologies IPO Portal